Early Aspirin Discontinuation Following Acute Coronary Syndrome or Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Early Aspirin Discontinuation Following Acute Coronary Syndrome or Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

The respective ischemic and bleeding risks of early aspirin discontinuation following an acute coronary syndrome (ACS) or percutaneous coronary intervention (PCI) remain uncertain. We performed a prospero-registered review of randomized controlled trials (RCTs) comparing a P2Y<sub>12</sub&g...

Full description

Bibliographic Details
Main Authors: Paul Guedeney, Jules Mesnier, Sabato Sorrentino, Farouk Abcha, Michel Zeitouni, Benoit Lattuca, Johanne Silvain, Salvatore De Rosa, Ciro Indolfi, Jean-Philippe Collet, Mathieu Kerneis, Gilles Montalescot
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Journal of Clinical Medicine
Subjects:
aspirin
p2y<sub>12</sub> inhibitors
antiplatelet therapy
acute coronary syndrome
percutaneous coronary intervention
Online Access:https://www.mdpi.com/2077-0383/9/3/680

Internet

https://www.mdpi.com/2077-0383/9/3/680

Similar Items